|
|
||||||||||||||
|
|
|||||||||||||||
RESEARCH PAPER |
1 Smeal College of Business, Penn State University, University Park, Pennsylvania, USA
2 Center for Health Promotion and Disease Prevention, Henry Ford Health System, Detroit, Michigan, USA
3 Department of Health Policy and Management, School of Public Health, Morgan State University, Baltimore, Maryland, USA
Correspondence to:
Professor Marvin E Goldberg
Smeal College of Business, Penn State University, University Park, Pennsylvania 16802, USA; mgold{at}psu.edu
Objectives: To identify key themes related to tobacco advertising and promotion in testimony provided by tobacco industry-affiliated witnesses in tobacco litigation, and to present countervailing evidence and arguments.
Methods: Themes in industry testimony were identified by review of transcripts of testimony in the Tobacco Deposition and Trial Testimony Archive (http://tobaccodocuments.org/datta) from a sample of defence witnesses, including three academic expert witnesses, six senior executives of tobacco companies, and one industry advertising consultant. Counterarguments to the themes embodied in defence testimony were based on information from peer-reviewed literature, advertising trade publications, government reports, tobacco industry documents, and testimony provided by expert witnesses testifying for plaintiffs.
Results: Five major themes employed by defence witnesses were identified: (1) tobacco advertising has a relatively weak "share of voice" in the marketing environment and is a weak force in affecting smoking behaviour; (2) tobacco advertising and promotion do not create new smokers, expand markets, or increase total tobacco consumption; (3) the tobacco industry does not target, study, or track youth smoking; (4) tobacco advertising and promotion do not cause smoking initiation by youth; and (5) tobacco companies and the industry adhere closely to relevant laws, regulations, and industry voluntary codes. Substantial evidence exists in rebuttal to these arguments.
Conclusions: Tobacco industry-affiliated witnesses have marshalled many arguments to deny the adverse effects of tobacco marketing activities and to portray tobacco companies as responsible corporate citizens. Effective rebuttals to these arguments exist, and plaintiffs attorneys have, with varying degrees of success, presented them to judges and juries.
Abbreviations: DATTA, Tobacco Deposition and Trial Testimony Archive; FCTC, Framework Convention on Tobacco Control; FDA, US Food and Drug Administration; FTC, Federal Trade Commission; IOM, Institute of Medicine; MSA, Master Settlement Agreement; OECD, Organisation for Economic Co-operation and Development; RJR, RJ Reynolds; STMSA, Smokeless Tobacco Master Settlement Agreement; USST, United States Smokeless Tobacco Company
Keywords: tobacco; smoking; marketing; advertising; legal cases
This article has been cited by other articles:
![]() |
D D. Blanke and H. H Humphrey III Putting truth into action: using the evidence for justice Tob. Control, December 1, 2006; 15(suppl_4): iv1 - iv3. [Full Text] [PDF] |
||||
![]() |
S. Milberger, R. M Davis, C. E Douglas, J. K Beasley, D. Burns, T. Houston, and D. Shopland Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick Tob. Control, December 1, 2006; 15(suppl_4): iv17 - iv26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wakefield, K. McLeod, and C. L Perry "Stay away from them until you're old enough to make a decision": tobacco company testimony about youth smoking initiation Tob. Control, December 1, 2006; 15(suppl_4): iv44 - iv53. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |